Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CFN

CareFusion (CFN) Stock Price, News & Analysis

CareFusion logo

About CareFusion Stock (NYSE:CFN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive CFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareFusion and its competitors with MarketBeat's FREE daily newsletter.

CFN Stock News Headlines

The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for it: "Elon Time." But this time... it’s different. A fleet of autonomous robotaxis is scheduled to be unleashed on the streets of Austin, Texas, this June.
Cofina SGPS S/A
Health Care Takeover Targets: Rumors Run Rampant
CareFusion Reaches New 52-Week High (CFN)
CareFusion Stock Hits New 52-Week High (CFN)
See More Headlines

CFN Stock Analysis - Frequently Asked Questions

CareFusion Corp (NYSE:CFN) issued its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.79 by $0.20. CareFusion's revenue for the quarter was up 15.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that CareFusion investors own include Bristol-Myers Squibb (BMY), Cardinal Health (CAH), American Electric Power (AEP), Allergan (AGN), Bank of America (BAC), Baxter International (BAX) and Chubb (CB).

Company Calendar

Last Earnings
2/05/2015
Today
5/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:CFN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:CFN) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners